![James Martin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 49 467 $ in data 31/05/2026
James Joseph Martin is currently Chief Financial Officer, Treasurer & Director at Non-Invasive Monitoring Systems, Inc. since 2023.
Mr. Martin is also Chief Financial Officer at Cocrystal Pharma, Inc. starting in 2026.
Former positions include Independent Director at Big Cypress Acquisition Corp.
from 2020 to 2021, Director at SAB Biotherapeutics, Inc. from 2020 to 2021, Chief Financial Officer at Vaporin, Inc. from 2014 to 2015, Controller at Avborne Heavy Maintenance, Inc. from 2005 to 2008, Chief Financial Officer at SafeStitch Medical, Inc. from 2011 to 2013, Controller at AAR Aircraft Services-Miami, Inc. from 2008 to 2010, Vice President-Finance at Aero Pharmaceuticals, Inc. in 2011, Chief Financial Officer at Healthier Choices Management Corp.
from 2014 to 2015, Chief Financial Officer at VBI Vaccines, Inc. from 2014 to 2016, and Chief Financial Officer at Motus GI Holdings, Inc. from 2016 to 2017.
Education includes undergraduate, graduate, and MBAistration degrees from Barry University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
COCRYSTAL PHARMA INC 0,32% | 09/01/2026 | 44.167 ( 0,32% ) | 49 467 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| NON-INVASIVE MONITORING SYSTEMS, INC. | Direttore Finanziario/CFO | 27/01/2011 |
| COCRYSTAL PHARMA, INC. | Direttore Finanziario/CFO | 23/02/2017 |
| Società | Posizione | Fine |
|---|---|---|
| BIG CYPR | Direttore/Membro del Consiglio | 22/10/2021 |
| SAB BIOTHERAPEUTICS, INC. | Direttore/Membro del Consiglio | 22/10/2021 |
| MOTUS GI HOLDINGS, INC. | Direttore Finanziario/CFO | 01/02/2017 |
| VBI VACCINES INC. | Direttore Finanziario/CFO | 01/11/2016 |
| HEALTHIER CHOICES MANAGEMENT CORP. | Direttore Finanziario/CFO | 15/09/2015 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
Non-Invasive Monitoring Systems, Inc.
 Non-Invasive Monitoring Systems, Inc. Financial ConglomeratesFinance Operates as a shell company with no operations | Finance |
Vaporin, Inc.
 Vaporin, Inc. TobaccoConsumer Non-Durables Distributes and markets vaporizers and e-liquids products | Consumer Non-Durables |
Barry University
 Barry University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avborne Heavy Maintenance, Inc.
 Avborne Heavy Maintenance, Inc. Other TransportationTransportation Provides aircraft maintenance, repair, and overhaul | Transportation |
SafeStitch Medical, Inc.
 SafeStitch Medical, Inc. Medical SpecialtiesHealth Technology Produces medical devices | Health Technology |
AAR Aircraft Services-Miami, Inc.
 AAR Aircraft Services-Miami, Inc. Aerospace & DefenseElectronic Technology Provides aircraft maintenance check, modification, installation and painting services | Electronic Technology |
Aero Pharmaceuticals, Inc.
 Aero Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Markets dermatology products | Retail Trade |
Healthier Choices Management Corp.
 Healthier Choices Management Corp. Food RetailRetail Trade Owns and operates natural and organic grocery stores and vape (alternative to cigarettes) stores | Retail Trade |
Cocrystal Pharma, Inc.
 Cocrystal Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for use in the treatment of human viral diseases | Health Technology |
VBI Vaccines, Inc.
 VBI Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Motus GI Holdings, Inc.
 Motus GI Holdings, Inc. Medical SpecialtiesHealth Technology Develops and supplies pure-vu systems | Health Technology |
Big Cypress Acquisition Corp.
 Big Cypress Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
SAB Biotherapeutics, Inc.
 SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
